Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 156

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 156
---
 provisions regarding noncompetition, confidentiality of information and assignment
of inventions. None of such agreements contain any terms providing for severance benefits. However, the enforceability of the noncompetition
provisions may be limited under applicable law. In addition, we intend to enter into indemnification agreements, subject to the listing
of our securities on the NYSE American, with each executive officer and director pursuant to which we will indemnify each of them up
to a certain amount and to the extent that these liabilities are not covered by directors and officers’ insurance.

We
have also entered into a Chief Financial Officer Services Agreement, or the CFO Services Agreement, dated December 5, 2022, with Shimony,
pursuant to which the Company retains CFO services from Shimony that are provided by Mr. Arie Gordashnikov. Mr. Gordashnikov, who has
been engaged by the Company since October 1, 2022, serves as the Chief Financial Officer of the Company and devotes all of the time and
effort required for our business and activities on a full-time basis. Pursuant to the CFO Services Agreement, Mr. Gordashnikov is expected
to continue to serve as our CFO following the completion of this offering, and the Company will pay Shimony $3,000 per month plus Value-Added
Tax for Mr. Gordashnikov’s services from such time as the Company completes an IPO. The CFO Services Agreement may be terminated
by either the Company or Shimony upon 60 days’ prior written notice. The CFO Services Agreement further provides that Mr. Gordashnikov
shall not provide CFO services to any third party and shall not engage in any other employment, consulting or other business activity
(whether full-time or part-time) that would create a conflict of interest with the Company. The CFO Services Agreement also includes
standard non-compete, non-solicitation and confidentiality provisions. In addition, Mr. Gordashnikov will enter into a standard indemnification
agreement with the Company.

For
a description of the terms of our options and option plans, see “Management—Equity Incentive Plan”below.

Directors’ Service Contracts

Other than with respect to
our directors that are also executive officers, we do not have written agreements with any director providing for benefits upon the termination
of his employment with our company.

<div align='center'>92</div>

Differences between the Companies Law and NYSE American Requirements

The Sarban